FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/30/2015 |
3. Issuer Name and Ticker or Trading Symbol
Blueprint Medicines Corp [ BPMC ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 143,486 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | (1) | 07/30/2024 | Common Stock | 53,475 | $1.87 | D | |
Stock Option (Right to Buy) | (2) | 07/30/2024 | Common Stock | 213,903 | $1.87 | D | |
Stock Option (Right to Buy) | (3) | 07/30/2024 | Common Stock | 163,080 | $1.87 | D | |
Stock Option (Right to Buy) | (4) | 02/10/2025 | Common Stock | 109,090 | $8.8 | D |
Explanation of Responses: |
1. This option is subject to an early exercise provision and is immediately exercisable. Shares subject to this option vest as follows: (i) 6,310 shares vest on each of December 21, 2015 and May 21, 2016, (ii) 11,957 shares vests on each of June 21, 2016, July 21, 2016 and August 21, 2016, and (iii) 4,984 shares vests on September 21, 2016. |
2. This option vests in four equal tranches and installments as follows: 53,476 shares vest in five installments at a rate of 11,957 shares on each of August 21, 2015, September 21, 2015, October 21, 2015 and November 21, 2015, and the remaining 5,648 shares veston December 21, 2015, (ii) 53,476 shares vests in five installments at a rate of 11,957 shares on each of January 21, 2016, February 21, 2016, March 21, 2016 and April 21, 2016, and the remaining 5,648 shares vest on May 21, 2016, (iii) 53,476 shares vest in five installments at a rate of 11,957 on each of January 21, 2017, February 21, 2017, March 21, 2017 and April 21, 2017, and the remaining 5,648 vest on May 21, 2017, and (iv) 53,475 shares vest in five installments at a rate of 11,957 shares on each of January 21, 2018, February 21, 2018, March 21, 2018 and April 21, 2018, and the remaining 5,647 shares vest on May 21, 2018. |
3. This option vests in three tranches and installments as follows: (i) 42,845 shares vest in four installments at a rate of 6,974 shares on September 21, 2016, and 11,957 shares on each of October 21, 2016 and November 21, 2016, and 11,957 shares on December 21, 2016, (ii) 90,010 shares vest in eight installments at a rate of 6,311 shares on May 21, 2017 and 11,957 shares on each of June 21, 2017, July 21, 2017, August 21, 2017, September 21, 2017, October 21, 2017, November 21, 2017 and December 21, 2017, and (iii) 30,225 shares vest in three installments at a rate of 6,311 shares on May 21, 2018, 11,957 on June 21, 2018 and 11,957 on July 21, 2018. |
4. This option vests in 48 equal monthly installments beginning on February 10, 2015. |
/s/ Christine Bellon, Attorney-in-Fact | 04/30/2015 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |